Europe — EMA
Octanine (Human Coagulation Factor Ix)
GNH USA supplies Octanine (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B and surgical bleeding.
Request sourcing
What is Human Coagulation Factor Ix?
Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It treats hemophilia B and is used in patients with factor IX deficiency. GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Ix used for?
Octanine is used in the management of bleeding disorders related to factor IX deficiency. It is indicated for: - Hemophilia B: Provides replacement of missing clotting factor to control and prevent bleeding episodes. - Perioperative management: Supplies factor IX to maintain hemostasis during and after surgery. - Trauma‑induced bleeding: Restores factor IX levels to aid clot formation in acute bleeding situations.
What are the side effects of Human Coagulation Factor Ix?
Octanine may cause a range of adverse reactions. Common Side Effects: - Headache - Fever - Nausea - Mild infusion‑site redness - Transient elevated liver enzymes - Fatigue Serious or Rare Side Effects: - Development of inhibitory antibodies against factor IX - Anaphylactic or severe hypersensitivity reactions - Thromboembolic events such as deep‑vein thrombosis - Severe hemolysis - Renal impairment - Disseminated intravascular coagulation (DIC)
What precautions apply to Human Coagulation Factor Ix?
When using Octanine, consider the following precautions: - Monitor factor IX activity levels: Adjust dosing based on laboratory results. - Assess for inhibitors: Test for anti‑factor IX antibodies before and during therapy. - Evaluate bleeding risk: Use caution in patients with a history of thrombosis. - Review concomitant anticoagulants: Adjust therapy to avoid excessive clotting or bleeding. - Pregnancy and lactation: Use only if clearly needed; weigh maternal benefits against potential fetal risk. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Coagulation Factor Ix interact with?
Octanine can interact with several medicines. Major Interactions (Avoid): - Activated protein C concentrates: May reduce efficacy of factor IX. - High‑dose aspirin or other antiplatelet agents: Increases bleeding risk. - Warfarin: May potentiate anticoagulant effect and complicate monitoring. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): May modestly increase bleeding tendency. - Heparin: Requires careful coagulation monitoring. - Antibiotics such as quinolones: Potential for altered plasma protein binding.



